Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/13348
Title: High-dose oral acyclovir reduces the incidence of cytomegalovirus infection in liver transplant recipients.
Austin Authors: Mollison, L C;Richards, Michael J;Johnson, Paul D R ;Hayes, K;Munckhof, Wendy J;Jones, Robert M ;Dabkowski, P D;Angus, Peter W 
Affiliation: Victorian Liver Transplant Unit
Issue Date: 1-Sep-1993
Publication information: The Journal of Infectious Diseases; 168(3): 721-4
Abstract: To determine the impact of high-dose oral acyclovir on cytomegalovirus (CMV) infection or disease after liver transplantation, CMV cultures were prospectively collected for 6 months after transplantation. The incidence and timing of infection and disease in patients receiving high-dose oral acyclovir (3200 mg/day) from day 7 until 3 months after transplantation were compared with an historical control group who received no acyclovir. All patients who did not receive acyclovir (group 1, n = 12) but only 57% of those who did (group 2, n = 22) had CMV infection (P = .008). Nine (75%) group 1 but only 3 (14%) group 2 patients had positive leucocyte cultures (P = .0007). Three group 1 patients developed CMV disease; 1 group 2 patient developed CMV hepatitis. Each of these 4 patients had CMV viremia (P = .01). The frequency of CMV infection after liver transplantation appears to be reduced by high-dose oral acyclovir.
URI: https://ahro.austin.org.au/austinjspui/handle/1/13348
ORCID: 
Journal: The Journal of Infectious Diseases
URL: https://pubmed.ncbi.nlm.nih.gov/8394862
Type: Journal Article
Subjects: Acyclovir.administration & dosage.therapeutic use
Administration, Oral
Adolescent
Adult
Aged
Child
Cytomegalovirus Infections.drug therapy.prevention & control
Female
Humans
Immunosuppression
Liver Transplantation
Male
Middle Aged
Time Factors
Viremia
Appears in Collections:Journal articles

Show full item record

Page view(s)

22
checked on Apr 12, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.